Optimi Health Corp. Common Shares Asset Resilience Ratio

Latest as of June 2026: 0.02%

Optimi Health Corp. Common Shares asset resilience ratio. Optimi Health Corp. Common Shares (OPTH) has an Asset Resilience Ratio of 0.02% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See OPTH defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$3.52K
Cash + Short-term Investments

Total Assets

$18.21 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Optimi Health Corp. Common Shares (2021–2025)

Asset resilience ratio of Optimi Health Corp. Common Shares from 2021 to 2025. This chart shows how Optimi Health Corp. Common Shares's Asset Resilience Ratio has changed over time. Read Optimi Health Corp. Common Shares (OPTH) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Optimi Health Corp. Common Shares's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Optimi Health Corp. Common Shares's balance sheet.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $3.52K 0.02%
Total Liquid Assets $3.52K 0.02%

Asset Resilience Insights

  • Limited Liquidity: Optimi Health Corp. Common Shares maintains only 0.02% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Optimi Health Corp. Common Shares Industry Peers by Asset Resilience Ratio

Compare Optimi Health Corp. Common Shares's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Galderma Group N
SW:GALD
Drug Manufacturers - Specialty & Generic 3.56%
Enzymatica publ AB
ST:ENZY
Drug Manufacturers - Specialty & Generic 22.17%
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 9.04%
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
Drug Manufacturers - Specialty & Generic 47.16%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%
Walvax BioTech
SHE:300142
Drug Manufacturers - Specialty & Generic 2.20%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%

Optimi Health Corp. Common Shares Asset Resilience Ratio by Year (2021–2025)

Optimi Health Corp. Common Shares asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for Optimi Health Corp. Common Shares.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-09-30 0.03% $5.01K $15.23 Million --
2022-09-30 0.00% $0.00 $16.82 Million --
2021-09-30 17.05% $4.00 Million $23.46 Million --
pp = percentage points

About Optimi Health Corp. Common Shares

NASDAQ:OPTH USA Drug Manufacturers - Specialty & Generic
Market Cap
$13.80 Million
Market Cap Rank
#26089 Global
#5479 in USA
Share Price
$2.41
Change (1 day)
-7.31%
52-Week Range
$2.41 - $5.97
All Time High
$5.97
About

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and… Read more